Prostate mpMRI in the UK: the state of the nation
The article discusses how advancements in multiparametric MRI (mpMRI) are enhancing prostate cancer diagnosis by reducing unnecessary biopsies and targeting significant cancers, despite ongoing challenges like geographical variation and limited resources.
Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
The article presents a consensus statement on prostate cancer active surveillance best practices in the UK, highlighting practice variations and the need for improved patient information and support.
Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010
The article reveals that Black men in England face significantly higher lifetime risks of prostate cancer diagnosis and mortality compared to White and Asian men, with the highest diagnosis and death rates among Black men, while mortality rates post-diagnosis are similar across ethnic groups.
The importance of real-world data in prostate cancer
Natalia Norori, Data & Evidence Manager at Prostate Cancer UK, helps us understand the importance of real- world data in prostate cancer.
The power of physical activity
Sarah Dewhurts, Physiotherapist and Service Lead at Physiotherapist and Service Lead, shares insights on the power of physical activity for your prostate cancer patients.
Considerations for transgender and gender diverse patients with prostate cancer
Stewarts O’Callagham, CEO at OUTpatients, Alison Berner, Academic Clinical Lecturer at the Barts Cancer Institute , and Lloyd Young, patient with lived experience, share their considerations on the LGBTQI+ prostate cancer patients.
Hormones Therapy: living well with ADT
Lisa O’Sullivan, Senior Specialist Nurse at Prostate Cancer UK, presents an overview on Hormone Therapy and Androgen Deprivation Therapy.
Risks, Counselling, and the importance of Active Surveillance
David Thurtle, senior urology registrar in the East of England, introduces you to the importance of Active Surveillance.
Active Surveillance – the Wild West of prostate cancer management
Vincent J Gnanapragasam, Professor of Urology in the University of Cambridge and an Honorary Consultant Urologist at Addenbrooke’s Hospital in Cambridge, presents the difficulties and challenges of Active Surveillance.
Equality, inclusivity, and holistic care of prostate cancer
Siva Tharshini Ramalingam, Cardio-Oncology Specialty Doctor at the Royal Brompton Hospital in London, shares insights on equality, inclusivity, and holistic care of prostate cancer.
